Bedfordshire and Luton Joint Prescribing Committee
Ref: JPC Bulletin 293
Bulletin Date: 14/01/21
Review Date: Dec 2023
Insulin Lyumjev® :- a new analogue formulation of insulin lispro
Insulin Lyumjev® (Lilly) :-
This is a new analogue insulin formulation of insulin lispro. It is formulated to be faster acting.
JPC Recommendation (based on the recommendations from the Diabetic Sub group):-
- The JPC supported the use of Insulin Lyumjev® as a treatment option for the same group of patients as Fiasp® with the exception that Insulin Lyumjev® is for adult patients only.
Click here to see the Fiasp® criteria